Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United Kingdom
/
Materials
Create a narrative
Croda International Community
LSE:CRDA Community
1
Narratives
written by author
0
Comments
on narratives written by author
20
Fair Values set
on narratives written by author
Create a narrative
Croda International
Popular
Undervalued
Overvalued
Community Investing Ideas
Croda International
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
Acquisition Of Solus Biotech And Asian Expansion Will Strengthen Future Outlook
Key Takeaways Strengthening local relationships and strategic acquisitions, particularly in Asia, should drive revenue through higher prices and increased manufacturing capacity. Targeting innovation and operational efficiencies, with a focus on mRNA products, positions Croda for growth in both consumer and pharma markets.
View narrative
UK£38.72
FV
21.5% undervalued
intrinsic discount
4.79%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
2 days ago
author updated this narrative
Your Valuation for
CRDA
CRDA
Croda International
Your Fair Value
UK£
Current Price
UK£30.38
54.8% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
2b
2015
2018
2021
2024
2025
2027
2030
Revenue UK£2.1b
Earnings UK£205.2m
Advanced
Set Fair Value